Bivalent second booster dose of the COVID-19 vaccine: Eligible populations’ reasons for receiving in Italy

The Italian Ministry of Health recommended the administration of the bivalent second booster dose of the new available mRNA COVID-19 vaccine for subjects aged 60 y and over, aged 12 y and over with high frailty motivated by concomitant/preexisting conditions, and health-care workers. The purposes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Della Polla, Giorgia, Miraglia del Giudice, Grazia, Pelullo, Concetta Paola, Angelillo, Italo Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088915/
https://www.ncbi.nlm.nih.gov/pubmed/36988622
http://dx.doi.org/10.1080/21645515.2023.2188856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088915/
https://www.ncbi.nlm.nih.gov/pubmed/36988622
http://dx.doi.org/10.1080/21645515.2023.2188856

Ejemplares similares